Works matching AU Se-Hoon Lee


Results: 241
    1
    2

    Clinical trial of nintedanib in patients with recurrent or metastatic salivary gland cancer of the head and neck: A multicenter phase 2 study (Korean Cancer Study Group HN14-01).

    Published in:
    2017
    By:
    • Kim, Youjin;
    • Lee, Su Jin;
    • Lee, Ji Yun;
    • Lee, Se‐Hoon;
    • Sun, Jong‐Mu;
    • Park, Keunchil;
    • An, Ho Jung;
    • Cho, Jae Yong;
    • Kang, Eun Joo;
    • Lee, Ha‐Young;
    • Kim, Jinsoo;
    • Keam, Bhumsuk;
    • Kim, Hye Ryun;
    • Lee, Kyoung Eun;
    • Choi, Moon Young;
    • Lee, Ki Hyeong;
    • Ahn, Myung‐Ju;
    • Lee, Se-Hoon;
    • Sun, Jong-Mu;
    • Lee, Ha-Young
    Publication type:
    journal article
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20

    A Phase 1b/2 Study of Alpelisib in Combination with Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.

    Published in:
    Targeted Oncology, 2023, v. 18, n. 6, p. 853, doi. 10.1007/s11523-023-00997-z
    By:
    • Razak, Albiruni R. Abdul;
    • Wang, Hung-Ming;
    • Chang, Jang-Yang;
    • Ahn, Myung-Ju;
    • Munster, Pamela;
    • Blumenschein Jr, George;
    • Solomon, Benjamin;
    • Lim, Darren Wan-Teck;
    • Hong, Ruey-Long;
    • Pfister, David;
    • Saba, Nabil F.;
    • Lee, Se-Hoon;
    • van Herpen, Carla;
    • Quadt, Cornelia;
    • Bootle, Douglas;
    • Blumenstein, Lars;
    • Demanse, David;
    • Delord, Jean-Pierre
    Publication type:
    Article
    21
    22
    23
    24
    25
    26
    27
    28

    Prognostic impact of clinicopathologic parameters in stage II/IIIbreast cancer treated with neoadjuvant docetaxel and doxorubicinchemotherapy: paradoxical features of the triple negative breastcancer.

    Published in:
    BMC Cancer, 2007, v. 7, p. 203, doi. 10.1186/1471-2407-7-203
    By:
    • Bhumsuk Keam;
    • Seock-Ah Im;
    • Hee-Jun Kim;
    • Do-Youn Oh;
    • Jee Hyun Kim;
    • Se-Hoon Lee;
    • Eui Kyu Chie;
    • Wonshik Han;
    • Dong-Wan Kim;
    • Woo Kyung Moon;
    • Tae-You Kim;
    • In Ae Park;
    • Dong-Young Noh;
    • Dae Seog Heo;
    • Sung Whan Ha;
    • Yung-Jue Bang
    Publication type:
    Article
    29
    30
    31
    32
    33
    34

    Identification of genomic mutations associated with clinical outcomes of induction chemotherapy in patients with head and neck squamous cell carcinoma.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2016, v. 142, n. 4, p. 873, doi. 10.1007/s00432-015-2083-2
    By:
    • Ock, Chan-Young;
    • Son, Bongjun;
    • Keam, Bhumsuk;
    • Lee, Seung-Youn;
    • Moon, Jaewoo;
    • Kwak, Hwanjong;
    • Kim, Sehui;
    • Kim, Tae;
    • Jeon, Yoon;
    • Kwon, Seong;
    • Hah, J. Hun;
    • Lee, Se-Hoon;
    • Kwon, Tack-Kyun;
    • Kim, Dong-Wan;
    • Wu, Hong-Gyun;
    • Sung, Myung-Whun;
    • Heo, Dae
    Publication type:
    Article
    35
    36
    37
    38
    39

    Biomarker role of thyroid irAE and PD-L1 positivity in predicting PD-1 blockade efficacy in patients with non-small cell lung cancer.

    Published in:
    Cancer Immunology, Immunotherapy, 2024, v. 73, n. 12, p. 1, doi. 10.1007/s00262-024-03852-w
    By:
    • Kim, Hye In;
    • Kim, Won Gu;
    • Kim, Mijin;
    • Ko, Nak Gyeong;
    • Jin, Mihyeon;
    • Jung, Hyun Ae;
    • Sun, Jong-Mu;
    • Ahn, Jin Seok;
    • Ahn, Myung-Ju;
    • Choi, Yoon-La;
    • Jeon, Min Ji;
    • Kim, Tae Yong;
    • Kim, Won Bae;
    • Kim, Sang-We;
    • Lee, Dae Ho;
    • Jang, Se Jin;
    • Kim, Sun Wook;
    • Chung, Jae Hoon;
    • Kim, Tae Hyuk;
    • Lee, Se-Hoon
    Publication type:
    Article
    40

    Biomarker role of thyroid irAE and PD-L1 positivity in predicting PD-1 blockade efficacy in patients with non-small cell lung cancer.

    Published in:
    Cancer Immunology, Immunotherapy, 2024, v. 73, n. 12, p. 1, doi. 10.1007/s00262-024-03852-w
    By:
    • Kim, Hye In;
    • Kim, Won Gu;
    • Kim, Mijin;
    • Ko, Nak Gyeong;
    • Jin, Mihyeon;
    • Jung, Hyun Ae;
    • Sun, Jong-Mu;
    • Ahn, Jin Seok;
    • Ahn, Myung-Ju;
    • Choi, Yoon-La;
    • Jeon, Min Ji;
    • Kim, Tae Yong;
    • Kim, Won Bae;
    • Kim, Sang-We;
    • Lee, Dae Ho;
    • Jang, Se Jin;
    • Kim, Sun Wook;
    • Chung, Jae Hoon;
    • Kim, Tae Hyuk;
    • Lee, Se-Hoon
    Publication type:
    Article
    41
    42
    43
    44
    45

    Prognosis Prediction of Measurable Enhancing Lesion after Completion of Standard Concomitant Chemoradiotherapy and Adjuvant Temozolomide in Glioblastoma Patients: Application of Dynamic Susceptibility Contrast Perfusion and Diffusion-Weighted Imaging.

    Published in:
    PLoS ONE, 2014, v. 9, n. 11, p. 1, doi. 10.1371/journal.pone.0113587
    By:
    • Kim, Jae Hyun;
    • Choi, Seung Hong;
    • Ryoo, Inseon;
    • Yun, Tae Jin;
    • Kim, Tae Min;
    • Lee, Se-Hoon;
    • Park, Chul-Kee;
    • Kim, Ji-Hoon;
    • Sohn, Chul-Ho;
    • Park, Sung-Hye;
    • Kim, Il Han
    Publication type:
    Article
    46
    47
    48
    49
    50